49 filings
Page 2 of 3
8-K
pekduo
30 Jun 23
AEON Biopharma and Priveterra Announce Arrangement of Up to $125 Million of Financing in Connection with Proposed Business Combination
8:26am
8-K
10yxx6c zmsb1md1
29 Jun 23
Entry into a Material Definitive Agreement
9:18pm
8-K
zk6uz 88x
28 Jun 23
Other Events
4:54pm
8-K
4qriufnznvk9sg
26 Jun 23
Other Events
4:07pm
8-K
jp7hfwu
21 Jun 23
Other Events
4:11pm
8-K
8e54khyh8 3yg5b
15 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:59pm
8-K
zjbhcvlf740f3zc71lfr
13 Jun 23
Other Events
4:47pm
8-K
gml suttnc93iswk
8 Jun 23
Other Events
7:37pm
8-K
823 mod9mknx
5 Jun 23
Other Events
9:33pm
8-K
k7brpa
23 May 23
Corporate Presentation May 2023
9:38pm
8-K
wzv wr5r7f
1 May 23
Entry into a Material Definitive Agreement
6:13am
8-K
8orkx7mpn3dpn y8
5 Apr 23
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:26pm
8-K
rp7h2k2
24 Feb 23
Regulation FD Disclosure
4:48pm
8-K
flqvpljpx2aecn8o
14 Feb 23
Regulation FD Disclosure
12:00am
8-K
9h0bwpk
10 Feb 23
Material Modifications to Rights of Security Holders
5:15pm
8-K
jrhf4492
6 Feb 23
Other Events
8:00am
8-K
lcpb3ymd6
11 Jan 23
Entry into a Material Definitive Agreement
4:48pm
8-K
wnn49 8g1ukior9b
10 Jan 23
AEON Biopharma and Priveterra Acquisition Corp. Announce Additional Capital Commitment from Existing Investors for at Least $20 Million
5:22pm
8-K
nce0jyg2
27 Dec 22
AEON Biopharma and Priveterra Acquisition Corp. Announce Filing of S-4 Registration Statement for Proposed Business Combination
5:04pm
8-K
xv2kzfb1 8icarzozwb
13 Dec 22
Entry into a Material Definitive Agreement
9:46am